News Releases

Mar 17, 2020

PPD, Inc. (Nasdaq:PPD) has been named by IDG’s CIO as a 2020 CIO 100 Awards honoree for deploying a data-visualization platform enabling PPD to more quickly visualize targeted patient populations and investigator sites conducting clinical trials for pharmaceutical and biotech customers, helping speed the development of life-changing medicines.

Mar 05, 2020
PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced that its management team will participate in the Barclays Global Healthcare Conference on March 11, 2020, at the Loews Miami Beach Hotel in Miami Beach, Florida.
Feb 05, 2020
PPD, Inc. (PPD) today announced the pricing of its initial public offering of 60 million shares of its common stock at $27.00 per share. Shares of PPD’s common stock are expected to begin trading on The Nasdaq Global Select Market on Feb. 6, 2020, under the symbol “PPD,” and the offering is expected to close on Feb. 10, 2020, subject to customary closing conditions.